These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35887070)

  • 1. Dysfunction of Mitochondria in Alzheimer's Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells.
    Atlante A; Valenti D; Latina V; Amadoro G
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New findings concerning vertebrate porin II--on the relevance of glycine motifs of type-1 VDAC.
    Thinnes FP
    Mol Genet Metab; 2013 Apr; 108(4):212-24. PubMed ID: 23419876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
    Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
    Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.
    Ferrer I
    J Bioenerg Biomembr; 2009 Oct; 41(5):425-31. PubMed ID: 19798558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
    Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
    Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
    Rhein V; Eckert A
    Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease.
    Bobba A; Amadoro G; Petragallo VA; Calissano P; Atlante A
    Biochim Biophys Acta; 2013 Jul; 1827(7):848-60. PubMed ID: 23583906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.
    Amadoro G; Corsetti V; Florenzano F; Atlante A; Ciotti MT; Mongiardi MP; Bussani R; Nicolin V; Nori SL; Campanella M; Calissano P
    Neurobiol Dis; 2014 Feb; 62():489-507. PubMed ID: 24411077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Yang Y; Jia X; Yang X; Wang J; Fang Y; Ying X; Zhang M; Wei J; Pan Y
    Brain Res; 2024 Jul; 1835():148920. PubMed ID: 38599511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Tau Protein on Mitochondrial Functions.
    Epremyan KK; Goleva TN; Zvyagilskaya RA
    Biochemistry (Mosc); 2022 Aug; 87(8):689-701. PubMed ID: 36171651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
    Reddy PH
    Biochim Biophys Acta; 2013 Jan; 1832(1):67-75. PubMed ID: 22995655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.